FDA’s CDRH sets goals for personalized medicine

Tuesday, January 24, 2012 02:51 PM

The FDA's Center for Devices and Radiological Health has set personalized medicine as one of its priorities for the current year, aiming for draft guidance on co-development of drugs and diagnostics by year's end.

In CDRH’s 2012 Strategic Priorities document, priority four is to proactively facilitate innovation and address unmet public health needs, anticipating emerging technological trends and public health challenges and partnering with federal and external stakeholders to facilitate the development of innovative, safe and effective medical devices and advance regulatory science.

Within this priority, one of CDRH’s strategies is to further develop a personalized medicine program. It will work collaboratively with federal government partners and external constituencies to assure the appropriate regulatory oversight of therapeutics and diagnostics when their safety and effectiveness are intimately tied to one another.

The center’s goals include continuing to develop policies and procedures to assure that safe and effective diagnostic products are either innovative themselves or provide innovative uses reach the public. By June 30, 2012, CDRH plans to clear final guidance on Companion Diagnostics. By Dec. 31, 2012, CDRH plans to clear draft guidance on co-development of drugs or biologics and devices.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs